THE GLOBAL PHARMACEUTICAL INDUSTRY

IN THIS XERFI GLOBAL REPORT :

MARKET ANALYSIS

In addition to a comprehensive view of the sector's environment and demand (macroeconomic factors, changes brought about by digital transformation and ecological transition, etc.), the study provides our exclusive analysis of the past evolution of the global pharmaceutical industry and its prospects. In particular, it outlines the impact of the health crisis and the lessons to be learned from the current situation.

COMPANIES' BUSINESS STRATEGIES

Rationalisation of drug portfolios, continued innovation efforts, digital transformation, offensive on the generics and biosimilars market, securing supplies of strategic raw materials : the report details the growth levers prioritised by the world leaders in the pharmaceutical industry, after analysing their main strengths and weaknesses.

EXPLANATION OF THE CHANGES IN THE COMPETITIVE LANDSCAPE

This report also provides an individualised and aggregated financial analysis of the operators' financial performance. In particular, it deciphers the evolution of sales and operating profit rate for the analysed companies.

1. EXECUTIVE SUMMARY

SUMMARY AND KEY PAGES OF THE REPORT

The summary provides all the elements needed to understand the major trends in the sector and foreseeable developments, drawing on analyses of the market outlook and the strategies of the companies.

2. MARKET FUNDAMENTALS

SCOPE OF THE REPORT

OVERVIEW

MARKET FUNDAMENTALS

3. THE MARKET AND LEADERS' ACTIVITY

SECTORAL ENVIRONMENT

• Overview

• The role of public authorities

• Demographic developments

THE GLOBAL PHARMACEUTICAL MARKET

• Key market indicators

• International trade

• The regional fact sheets

LEADERS' ACTIVITY AND PERFORMANCES

• Revenue

• Operating profit rate

• Individualised activity and performance

4. COMPETITION AND LEADERS' STRATEGIES

COMPETITIVE ENVIRONMENT

• Overview

• Competitive intensity

• Threat of new entrants

• Government's influence

• Threat of substitutes

• Bargaining power of suppliers

LEADERS' STRATEGIES

• Overview

• Rationalisation of drug portfolios

• Continued innovation efforts

• The generic and biosimilar market offensive

• The digital transformation of the business

• The internationalisation of the business

• Securing supplies

5. SOURCES

6. ANNEXES

7. FORCES AT WORK

• Rankings of the 10 world leaders in the global pharmaceutical industry

• Key performance indicators of the 10 leaders (revenue growth and EBIT rate)

• SWOT analysis of the 10 leaders

8. LEADERS' PROFILES

• PFIZER

• JOHNSON & JOHNSON

• ROCK

• ABBVIE

• GSK

• BMS

• SANOFI

• MERCK & CO

• NOVARTIS

• ASTRAZENECA

PFIZER

JOHNSON & JOHNSON

ROCK

ABBVIE

GSK

BMS

SANOFI

MERCK & CO

NOVARTIS

ASTRAZENECA